MET and prostate carcinoma: In our study, we found a positive correlation between the expression of both MET and HGF and the expression of FOXP2 in prostate cancer tissues, FOXP2-overexpressing human prostate epithelial cells RWPE-1, and FOXP2-overexpressing NIH3T3 cells.